ILT tooth whitening laser placements will not be slowed by warning letter, firm says.
This article was originally published in The Gray Sheet
ION LASER TECHNOLOGY'S TOOTH WHITENING CENTER EQUIPMENT PLACEMENTS will not be delayed by a recent FDA warning letter citing violations of two of its tooth-whitening lasers, the company says in a June 26 release responding to the letter. ILT says the deficiencies are relatively minor, and that FDA has indicated that the firm can continue to ship products while corrections are made.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.